National CMOP CHLORHEXIDINE GLUCONATE
ID: 36C77025Q0104Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/ff1d41db309d415eac9b150b2c757dab/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting quotes for the procurement of Chlorhexidine Gluconate 4% Top Liquid (120ML) through RFQ 36C77025Q0104, aimed at supplying various VA Consolidated Mail Outpatient Pharmacy (CMOP) facilities. Vendors are required to submit their quotes by January 31, 2025, at 4:00 PM CST, along with necessary documentation including a signed solicitation cover page, an Excel pricing schedule, and proof of a valid State Wholesale Distributor License. This procurement is critical for ensuring the availability of pharmaceuticals that meet the healthcare needs of veterans, with strict compliance to federal regulations and quality standards mandated throughout the process. Interested vendors can reach out to Sarah Fry at sarah.fry2@va.gov or call 913-758-9935 for further inquiries.

    Point(s) of Contact
    Sarah Fry
    (913) 758-9935
    sarah.fry2@va.gov
    Files
    Title
    Posted
    S02_Pricing Schedule_Q0104.xlsx
    The National CMOP is soliciting quotes through RFQ 36C77025Q0104 for the supply of Chlorhexidine Gluconate 4% Top Liquid (120ML) to various VA CMOP facilities. Vendors are required to submit their quotes by January 31, 2025, at 4:00 PM CST, including a signed solicitation cover page (SF1449), an Excel quote spreadsheet, and documentation of a valid State Wholesale Distributor License. Additionally, non-domestic vendors must provide a Buy American Act certificate and OEM authorization for over-the-counter products. All pharmaceuticals must have a minimum expiration date of one year from the delivery date, detailed in "Vendor Comments." The quantities specified range from 1,000 to 2,400 units for delivery to multiple locations, emphasizing compliance with federal regulations for procurement. This request aims to meet the supply demands of VA CMOP facilities while promoting small business participation and adherence to U.S. purchasing policies.
    S02_RFQ_Q0104.pdf
    The document outlines a Request for Quotation (RFQ) issued by the Department of Veterans Affairs for the procurement of Chlorhexidine Gluconate 4% Top Liquid in various quantities. The RFQ details the submission requirements, including pricing schedules, necessary licenses, and other compliance documentation that vendors must provide. Key stipulations include the need for pharmaceuticals to have specific labeling such as bar code compliance and adherence to the Drug Supply Chain Security Act. The delivery schedule indicates shipments must occur to multiple specified locations within 10 days of order placement. Invoices must be submitted electronically, following designated formats and protocols. The document emphasizes the necessity for contractors to maintain rigorous standards regarding product quality, acceptance, and payment processes, as well as restrictions against gray market goods. Adherence to federal regulatory clauses related to contract management and performance is mandated. Overall, this RFQ serves to establish a structured procurement process ensuring the quality and reliability of pharmaceuticals for veteran healthcare services.
    S03_PRESOL_Q0104.pdf
    The Department of Veterans Affairs aims to procure Chlorhexidine Gluconate 4% topical liquid for various CMOP facilities, outlined in solicitation number 36C77025Q0104. The procurement is designated as a small business set-aside, with an estimated issue date for the solicitation on January 24, 2025, and a response deadline set for January 31, 2025. The delivery timeframe is 10 days after order receipt, requiring interested vendors to be registered on SAM.gov and submit specific documentation, including a signed SF1449, a pricing schedule, and proof of state licensing in compliance with the Drug Supply Chain Security Act. Proposal submissions must be directed to the contracting office contact, Sarah Fry, via email. This presolicitation notice reflects the VA's commitment to ensuring access to essential pharmaceuticals while adhering to federal procurement regulations and supporting small business participation.
    Lifecycle
    Title
    Type
    National CMOP CHLORHEXIDINE GLUCONATE
    Currently viewing
    Presolicitation
    National CMOP CHLORHEXIDINE GLUCONATE
    Solicitation
    Similar Opportunities
    6505--Domestic Pharmaceuticals/Med/Surge
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is conducting a Sources Sought notice to identify qualified domestic pharmaceutical manufacturers capable of supplying a range of medications for the Consolidated Mail Outpatient Pharmacy (CMOP). The procurement aims to ensure a reliable supply of domestically manufactured pharmaceuticals, including glucose test strips, hypertension treatments, and various other essential medications. This initiative is crucial for maintaining the health and well-being of veterans, as it supports ongoing healthcare needs. Interested manufacturers must submit their capability statements by February 5, 2025, to Josie Linaweaver at josie.linaweaver@va.gov, and are reminded to register in the System for Award Management (SAM) prior to contract award.
    6505--Fluticasone Propionate 50 MCG/Spray Soln, Nasal, 16GM
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Fluticasone Propionate 50 MCG/Spray solution, nasal, 16GM, intended for use by various federal agencies including the Department of Defense, Bureau of Prisons, and Indian Health Service. The objective of this procurement is to secure a reliable and uninterrupted supply of this medication for a contract period of one year, with the possibility of four additional one-year extensions. This medication is crucial for treating nasal conditions, and the estimated annual requirement is approximately 5,784,828 bottles. The solicitation will be available electronically on or around February 11, 2025, with a closing date set for February 25, 2025. Interested vendors should direct inquiries to Michael Olszewski at michael.olszewski@va.gov or call 708-786-4966.
    Cloth, Chlorhexidine Gluconate Pre-Op Prep
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Cloth, Chlorhexidine Gluconate Pre-Op Prep products, with a presolicitation notice expected to be released on or about February 2, 2025. This initiative aims to solicit information and evaluate products such as single-use, rinse-free cloths pre-saturated with 2% Chlorhexidine Gluconate, which are essential for skin antisepsis prior to surgical procedures. Vendors interested in participating must have a Distribution and Pricing Agreement (DAPA) and ensure their products are manufactured in a Trade Agreements Act (TAA) compliant country, with all relevant details to be made available on the SAM.gov website upon the QSL announcement. For further inquiries, interested parties can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil.
    6505--Mycophenolate Mofetil RFP
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) numbered 36E79725R0010 for the procurement of Mycophenolate Mofetil tablets and capsules, intended for use by the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The procurement aims to secure a reliable source of supply for these essential medications, with a contract term of one year and the option to extend for four additional years, emphasizing the importance of uninterrupted access to critical pharmaceuticals for veterans and associated federal programs. Interested offerors must comply with specific packaging requirements, including child-resistant closures for smaller bottles, and are encouraged to check the designated URL for updates, with the solicitation expected to be issued around February 14, 2025, and offers accepted until February 28, 2025. For inquiries, potential bidders can contact Amber Zavala at amber.zavala@va.gov or by phone at (708) 786-5245.
    6505--Bevacizumab Injection
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to procure Bevacizumab Injections through a Request for Proposal (RFP) designated as 36E79725R0019. This procurement aims to secure an uninterrupted supply of Bevacizumab, a critical pharmaceutical product used in the treatment of various medical conditions, for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will span one year with four additional one-year option periods, and the estimated annual requirements include various package sizes of Bevacizumab, with a total estimated usage of over 100,000 vials. Interested offerors must submit their proposals by March 4, 2025, at 2:30 PM Central Time, and can direct inquiries to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov or by phone at 708-786-5186.
    6505--Tamsulosin Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Tamsulosin Hydrochloride capsules as part of its Pharmaceutical Prime Vendor (PPV) Programs. Offerors are required to submit pricing for a base year and four option years, ensuring compliance with FDA standards and providing a unique 11-digit National Drug Code (NDC) for each product. This procurement is vital for maintaining a consistent supply of necessary pharmaceuticals to federal healthcare facilities, adhering to regulatory standards while ensuring availability and pricing stability. Interested parties must submit their offers by February 24, 2025, at 2:30 PM CST, and can contact Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further information.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Rituximab and Biosimilars
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) designated as 36E79725R0021 for the procurement of Rituximab and its biosimilars, aimed at ensuring a reliable supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will span one year with four additional one-year options, emphasizing the necessity of maintaining an uninterrupted supply chain for these critical medications. Offerors must provide the exact product names along with unique National Drug Codes (NDC), with estimated annual requirements of 17,858 vials of Rituximab 10mg/ml and 25,111 vials of the 50mg/ml variant. The solicitation is expected to be published around February 17, 2025, with a closing date around March 4, 2025; interested parties should direct inquiries to Deb Fassl at Deborah.Fassl@va.gov.
    6515--Pharmacy Management System ScriptPro Brand name or Equal
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of a ScriptPro Pharmacy Management System or an equivalent solution, as outlined in the combined synopsis/solicitation RFQ 36C26225Q0148. This procurement aims to enhance pharmacy management capabilities across various Veterans Integrated Service Network (VISN) 22 medical facilities and clinics, ensuring high-quality healthcare service delivery through reliable technological advancements. Interested vendors are encouraged to participate, particularly small businesses, including those owned by veterans and women, with bids due by February 4, 2025, at 7:00 AM PST. For inquiries, potential bidders should contact Contracting Officer Anthony Dela Cruz at anthony.delacruz@va.gov or by phone at 562-766-2284.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is soliciting quotes for the Pharmacy Uniform Formulary Blanket Purchase Agreement and the Uniform Formulary Additional Discount Program, aimed at establishing an effective pharmacy benefits program for the Military Health System. This procurement involves the evaluation and selection of pharmaceutical agents based on their clinical and cost-effectiveness, with a focus on newly approved drugs that will be reviewed by the Pharmacy and Therapeutics Committee in February 2025. Interested vendors must submit their pricing information, including National Drug Codes (NDCs), by December 19, 2024, and are encouraged to participate in a pre-quotation teleconference on December 4, 2024. For further inquiries, vendors can contact Tracy Banks at tracy.e.banks2.civ@mail.mil or Julia Trang at julia.n.trang.civ@health.mil.